Repertoire Partners’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$42.7M Sell
6,013,200
-11,800
-0.2% -$87.9K 29.9% 2
2025
Q1
$52.7M Buy
6,025,000
+3,627,000
+151% +$38.2M 23.22% 3
2024
Q4
$30.3M Buy
2,398,000
+948,000
+65% +$11.4M 12.04% 3
2024
Q3
$16.3M Buy
+1,450,000
New +$17M 18.27% 2

Other funds holding OSG

Repertoire Partners's OSG Position: Q2 2025 in Review

Repertoire Partners reduced its Octave Specialty Group (OSG) stake by 39% in Q2 2025, selling an estimated $3.37M and leaving 721,188 shares worth $5.12M. The position accounts for 3.59% of the portfolio, ranked #4.

Repertoire Partners first reported a position in OSG in Q4 2021 and has held it in 15 quarters since. The position peaked at $34.9M in Q4 2022. 146 funds tracked by Wall St. Rank hold OSG as of Q2 2025.

  • Repertoire Partners held 721,188 shares of Octave Specialty Group worth $5.12M as of Q2 2025.
  • Repertoire Partners sold 452,686 Octave Specialty Group shares in Q2 2025, an estimated $3.37M.
  • Octave Specialty Group made up 3.59% of Repertoire Partners's portfolio in Q2 2025, its #4 holding.
  • Repertoire Partners first reported a position in Octave Specialty Group in Q4 2021 and has held it in 15 quarters since.
  • Repertoire Partners's Octave Specialty Group position peaked at $34.9M in Q4 2022.
  • 146 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2025.

Based on Repertoire Partners's 13F filing for Q2 2025, filed 14 Aug 2025.